GLP-1glp-1 receptor agonistspharmacy educationpharmacovigilanceobesity

Saudi pharmacy students score 7.6 of 17 on GLP-1 safety knowledge

Only 37 percent knew hypoglycemia is uncommon with GLP-1 receptor agonist monotherapy, the cross-sectional survey found.

By Maren Holt · Senior Reporter, GLP-1

Oct 17 07:00 ETSource: The Libyan journal of medicine

The wire

01Of 1,118 eligible Pharm.D. students at Umm Al-Qura University, 296 responded between November and December 2025; mean knowledge score was 7.6 plus or minus 4.0 out of 17 items.
02Pharmacists are often the last check on GLP-1 counseling, and gaps on rodent thyroid C-cell tumors (25 percent recognition) and retinopathy (36.5 percent) bear on patient conversations.
03Response rate was 26.5 percent at a single institution with an author-developed questionnaire, limiting generalizability beyond that program.

From the source

Pharmacy students' knowledge and attitudes regarding GLP-1 receptor agonist adverse effects in obesity management: a cross-sectional study
The Libyan journal of medicine · 2026 Dec 31 · Khojah AA, Gazzaz MJ, Aldurdunji MM et al.

Read at pubmed.ncbi.nlm.nih.gov

Source URL https://pubmed.ncbi.nlm.nih.gov/42886550/